While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

The purchase is the latest in a slew of efforts to invest in its neuroscience portfolio as Humira faces generic competition.

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...

(JAMA Neurology) The investigational anti-tau antibody bepranemab missed its primary cognitive endpoint in a phase II trial ...